March 2018 HPV Vaccination Supplement

The question of whether a state has the right to institute a mandatory vaccination policy against human papillomavirus (HPV) for school children remains hotly disputed.

Human papillomavirus infection (HPV) is a known cause for virtually all cases of cervical and anal cancers and about 70% of oropharyngeal cancer cases.

As the margin between acquisition cost and sales price continues to narrow for traditional community pharmacy medication dispensing, many pharmacies are increasingly turning to service-based opportunities to improve their profitability.

Vaccinations are often given to protect populations whose immune systems are most vulnerable, but pharmacists are aware that some vaccinations are also important during the adolescent and young-adult years.

Pharmacists have long been considered among the most accessible and trusted health care advisers.

Human papillomavirus (HPV) consists of a group of more than 150 related viruses, some of which have been identified as causes of certain types of cancer.

The 9-valent human papillomavirus (HPV) recombinant vaccine (Gardasil 9, Merck & Company, Inc.) is indicated for women and men aged 9 to 26 years for the prevention of certain diseases, precancerous lesions, and genital warts caused by HPV.